2025
SJR Q1
JCR Q1 · 4,5
SCIE
Dergi ayrıntısı
Current Opinion in Lipidology
- Yayıncı
- Lippincott Williams and Wilkins
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0957967214736535
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,348
- Quartile Q1
- H-Index 142
- Atıf/yayın 4,13
- Doküman (3y) 145
- Atıf (3y) 622
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,5
- 5Y JIF 4,6
- JCI 0,6
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cardiology and Cardiovascular Medicine Q1
- Cell Biology Q2
- Endocrinology, Diabetes and Metabolism Q1
- Genetics Q1
- Molecular Biology Q2
- Nutrition and Dietetics Q1
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Nursing
WoS kategorileri
- Biochemistry & Molecular Biology | Endocrinology & Metabolism | Peripheral Vascular Diseases
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,348 | 4,5 | 4,6 | 0,6 | Q2 | 142 |
| 2024 | Q1 | Q1 | 1,342 | 4,6 | 4,1 | 0,57 | Q3 | 138 |
| 2023 | Q1 | Q1 | 1,232 | 3,9 | 3,9 | 0,61 | Q2 | 138 |
| 2022 | Q1 | Q2 | 1,032 | 4,4 | 4,3 | 0,55 | Q2 | 138 |
| 2021 | Q1 | Q2 | 1,105 | 4,6 | 5,5 | 0,6 | Q2 | 138 |
| 2020 | Q1 | Q2 | 1,412 | 4,8 | 5 | 0,65 | Q2 | 138 |
| 2019 | Q1 | Q1 | 1,524 | 4,3 | 4,3 | 0,75 | Q2 | 138 |
| 2018 | — | Q1 | — | 4,8 | 4,7 | 0,74 | Q2 | — |
| 2017 | Q1 | Q1 | 1,847 | 3,9 | 4,1 | 0,69 | Q2 | 138 |
| 2016 | Q1 | Q1 | 1,777 | 4,1 | 4,5 | — | — | 138 |
| 2015 | Q1 | Q1 | 2,476 | 5,3 | 5,2 | — | — | 138 |
| 2014 | Q1 | Q1 | 2,457 | 5,7 | 5,7 | — | — | 138 |
| 2013 | Q1 | Q1 | 2,591 | 5,8 | 6 | — | — | 138 |
| 2012 | Q1 | Q1 | 2,515 | 5,8 | 5,7 | — | — | 138 |
| 2011 | Q1 | Q1 | 2,603 | 6,1 | 5,4 | — | — | 138 |
| 2010 | Q1 | Q1 | 2,522 | 6,6 | 6 | — | — | 138 |
| 2009 | — | Q1 | — | 6,1 | 5,6 | — | — | — |
| 2008 | — | Q1 | — | 6,6 | 5,9 | — | — | — |
| 2007 | — | Q1 | — | 6,2 | 5,9 | — | — | — |
| 2006 | — | Q1 | — | 5,7 | — | — | — | — |
| 2005 | — | Q1 | — | 5,3 | — | — | — | — |
| 2004 | — | Q1 | — | 6,2 | — | — | — | — |
| 2003 | — | Q1 | — | 7 | — | — | — | — |
| 2002 | — | Q1 | — | 6,6 | — | — | — | — |
| 2001 | — | Q1 | — | 7 | — | — | — | — |
| 2000 | — | Q1 | — | 5,7 | — | — | — | — |
| 1999 | — | Q1 | — | 5,8 | — | — | — | — |
| 1998 | — | Q1 | — | 4,1 | — | — | — | — |
| 1997 | — | Q1 | — | 3,4 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 103/328 |
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q3 | 58/198 |
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q2 | 22/100 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 82/320 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q3 | 43/193 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q3 | 16/98 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 106/313 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q3 | 51/186 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q2 | 17/96 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 103/285 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q3 | 45/145 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 23/68 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 133/297 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q3 | 61/146 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 25/67 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 99/295 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q3 | 48/146 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 18/65 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 85/297 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q2 | 33/143 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q2 | 12/65 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q2 | 51/299 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q2 | 26/145 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q2 | 8/65 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 82/293 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q3 | 41/142 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q2 | 14/65 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 76/290 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 35/138 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 11/63 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 43/289 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 19/133 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 7/63 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 41/290 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 17/128 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 7/60 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 42/291 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 14/124 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 6/65 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 43/290 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 15/122 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 8/68 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 39/290 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 14/122 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 5/68 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 36/286 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 12/116 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 5/68 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 37/283 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 11/105 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 6/61 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 34/275 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 8/93 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 5/56 |
| 2007 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 35/263 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 8/92 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 6/54 |
| 2006 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 43/262 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 10/93 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 6/52 |
| 2005 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 42/261 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 11/89 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 7/51 |
| 2004 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 34/261 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 7/87 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 4/51 |
| 2003 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 26/261 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 8/88 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 3/52 |
| 2002 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 29/266 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 6/88 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 4/52 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 32/308 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 4/90 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 4/50 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 41/310 |
| 2000 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 8/89 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 4/45 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 31/295 |
| 1999 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 7/85 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 3/44 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 53/295 |
| 1998 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 13/83 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 6/39 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 54/253 |
| 1997 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 15/81 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 7/38 |